TENET HEALTHCARE CORP (THC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q1 '17: 4.8B Q2 '17: 5.2B Q3 '17: 4.9B Q4 '17: 5.3B Q1 '18: 4.7B Q2 '18: 4.5B Q3 '18: 4.5B Q4 '18: 4.6B Q1 '19: 4.5B Q2 '19: 4.6B Q3 '19: 4.6B Q4 '19: 4.8B Q1 '20: 4.5B Q2 '20: 3.6B Q3 '20: 4.6B Q4 '20: 4.9B Q1 '21: 4.8B Q2 '21: 5B Q3 '21: 4.9B Q4 '21: 4.9B Q1 '22: 4.7B Q2 '22: 4.6B Q3 '22: 4.8B Q4 '22: 5B Q1 '23: 5B Q2 '23: 5.1B Q3 '23: 5.1B Q4 '23: 5.4B Q1 '24: 5.4B Q2 '24: 5.1B Q3 '24: 5.1B Q4 '24: 5.1B Q1 '25: 0 Q2 '25: 0 Q3 '25: 5.3B Q4 '25: 5.5B Q1 '26: 413M Q2 '26: 413M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 1.5B 3B 4.5B Q3 '16: 339M Q4 '16: 280M Q1 '17: 267M Q2 '17: 310M Q3 '17: 51M Q4 '17: 485M Q1 '18: 517M Q2 '18: 406M Q3 '18: 320M Q4 '18: 394M Q1 '19: 381M Q2 '19: 400M Q3 '19: 302M Q4 '19: 454M Q1 '20: 327M Q2 '20: 471M Q3 '20: 271M Q4 '20: 920M Q1 '21: 520M Q2 '21: 586M Q3 '21: 1B Q4 '21: 751M Q1 '22: 648M Q2 '22: 553M Q3 '22: 596M Q4 '22: 536M Q1 '23: 603M Q2 '23: 604M Q3 '23: 568M Q4 '23: 735M Q1 '24: 3.3B Q2 '24: 761M Q3 '24: 1.1B Q4 '24: 821M Q1 '25: 943M Q2 '25: 823M Q3 '25: 889M Q4 '25: 853M Q1 '26: 1.3B Q2 '26: 1.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-800M 0 800M 1.6B 2.4B Q3 '16: 80M Q4 '16: 23M Q1 '17: 36M Q2 '17: 32M Q3 '17: -289M Q4 '17: -99M Q1 '18: 191M Q2 '18: 108M Q3 '18: 65M Q4 '18: 102M Q1 '19: 72M Q2 '19: 121M Q3 '19: -146M Q4 '19: 124M Q1 '20: 159M Q2 '20: 169M Q3 '20: -106M Q4 '20: 546M Q1 '21: 222M Q2 '21: 257M Q3 '21: 578M Q4 '21: 419M Q1 '22: 280M Q2 '22: 179M Q3 '22: 268M Q4 '22: 274M Q1 '23: 296M Q2 '23: 293M Q3 '23: 266M Q4 '23: 456M Q1 '24: 2.3B Q2 '24: 477M Q3 '24: 681M Q4 '24: 572M Q1 '25: 622M Q2 '25: 522M Q3 '25: 579M Q4 '25: 644M Q1 '26: 906M Q2 '26: 1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 800M 1.6B 2.4B Q1 '16: 147M Q2 '16: 435M Q3 '16: 269M Q1 '17: 186M Q2 '17: 215M Q3 '17: 308M Q4 '17: 491M Q1 '18: 113M Q2 '18: 348M Q3 '18: 338M Q4 '18: 250M Q1 '19: 10M Q2 '19: 284M Q3 '19: 419M Q4 '19: 520M Q1 '20: 129M Q2 '20: 2.2B Q3 '20: 593M Q4 '20: 446M Q1 '21: 534M Q2 '21: 245M Q3 '21: 432M Q4 '21: 357M Q1 '22: 228M Q2 '22: 119M Q3 '22: 315M Q4 '22: 421M Q1 '23: 449M Q2 '23: 598M Q3 '23: 503M Q4 '23: 824M Q1 '24: 586M Q2 '24: 747M Q3 '24: 1B Q1 '25: 815M Q2 '25: 936M Q3 '25: 1.1B Q4 '25: 731M Q1 '26: 1.6B Q2 '26: 585M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-800M 0 800M 1.6B 2.4B Q1 '16: -61M Q2 '16: 230M Q3 '16: 68M Q1 '17: -12M Q2 '17: 65M Q3 '17: 164M Q4 '17: 276M Q1 '18: -30M Q2 '18: 223M Q3 '18: 202M Q4 '18: 37M Q1 '19: -182M Q2 '19: 140M Q3 '19: 263M Q4 '19: 342M Q1 '20: -53M Q2 '20: 2.1B Q3 '20: 507M Q4 '20: 280M Q1 '21: 413M Q2 '21: 123M Q3 '21: 321M Q4 '21: 53M Q1 '22: 73M Q2 '22: -33M Q3 '22: 150M Q4 '22: 131M Q1 '23: 214M Q2 '23: 466M Q3 '23: 327M Q4 '23: 616M Q1 '24: 346M Q2 '24: 602M Q3 '24: 829M Q1 '25: 642M Q2 '25: 743M Q3 '25: 778M Q4 '25: 367M Q1 '26: 1.5B Q2 '26: 417M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '13: 103M Q3 '13: 103.1M Q1 '14: 97.2M Q2 '14: 97.7M Q3 '14: 100.9M Q1 '15: 100.9M Q2 '15: 99.2M Q3 '15: 99.5M Q1 '16: 98.8M Q2 '16: 99.3M Q3 '16: 99.5M Q1 '17: 100M Q2 '17: 100.6M Q3 '17: 100.8M Q1 '18: 102.7M Q2 '18: 104.2M Q3 '18: 102.4M Q1 '19: 102.8M Q2 '19: 104.6M Q3 '19: 103.6M Q1 '20: 105.7M Q2 '20: 105.6M Q3 '20: 105.3M Q1 '21: 108.1M Q2 '21: 108.6M Q3 '21: 108.8M Q1 '22: 112M Q2 '22: 108.8M Q3 '22: 109.9M Q1 '23: 106M Q2 '23: 104.8M Q3 '23: 104.4M Q1 '24: 100.6M Q2 '24: 98.4M Q3 '24: 96.7M Q1 '25: 95M Q2 '25: 91.8M Q3 '25: 88.6M Q1 '26: 87.6M Q2 '26: 84M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 0.00 15.00 30.00 45.00 Q3 '10: 1.94 Q4 '10: 8.16 Q1 '11: 8.13 Q2 '11: 8.19 Q3 '11: 6.56 Q4 '11: 0.48 Q1 '12: 0.87 Q2 '13: -0.53 Q3 '13: -0.63 Q4 '13: -1.32 Q1 '14: -0.80 Q2 '15: 0.58 Q3 '15: 0.20 Q4 '15: -1.41 Q1 '16: -2.48 Q2 '16: -2.33 Q3 '17: -5.51 Q4 '17: -6.99 Q1 '18: -5.50 Q2 '20: -0.50 Q3 '20: -0.18 Q4 '20: 3.71 Q1 '21: 3.73 Q2 '21: 4.00 Q3 '21: 9.99 Q4 '21: 8.42 Q1 '22: 8.80 Q2 '23: 4.60 Q3 '23: 4.38 Q4 '23: 5.71 Q1 '24: 25.77 Q2 '24: 27.26 Q3 '24: 31.21 Q4 '24: 32.34 Q1 '25: 15.23 Q2 '25: 15.73 Q3 '25: 14.70 Q4 '25: 15.48 Q1 '26: 19.22 Q2 '26: 25.92 Q3 '11 Q4 '13 Q1 '16 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.